Jeffrey M Jonas is of Sage Therapeutics, Inc.. Currently has a direct ownership of 128,046 shares of SAGE, which is worth approximately $621,023. The most recent transaction as insider was on Nov 28, 2023, when has been sold 3,935 shares (Common Stock) at a price of $19.27 per share, resulting in proceeds of $75,827. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 128K
0% 3M change
4.97% 12M change
Total Value Held $621,023

JEFFREY M JONAS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 28 2023
SELL
Payment of exercise price or tax liability
$75,827 $19.27 p/Share
3,935 Reduced 2.98%
128,046 Common Stock
Nov 28 2023
BUY
Grant, award, or other acquisition
-
10,000 Added 7.04%
131,981 Common Stock
Feb 10 2023
SELL
Open market or private sale
$520,325 $44.69 p/Share
11,643 Reduced 8.71%
121,981 Common Stock
Feb 10 2023
BUY
Exercise of conversion of derivative security
$5,239 $0.45 p/Share
11,643 Added 8.01%
133,624 Common Stock
Feb 03 2023
SELL
Payment of exercise price or tax liability
$63,016 $44.16 p/Share
1,427 Reduced 1.16%
121,981 Common Stock
Feb 03 2023
BUY
Grant, award, or other acquisition
-
5,100 Added 3.97%
123,408 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
$71,603 $28.63 p/Share
2,501 Added 2.07%
118,308 Common Stock
Apr 27 2022
BUY
Exercise of conversion of derivative security
$13,925 $0.45 p/Share
30,944 Added 21.09%
115,807 Common Stock
Feb 17 2022
BUY
Exercise of conversion of derivative security
$1,800 $0.45 p/Share
4,000 Added 4.5%
84,863 Common Stock
Oct 19 2021
SELL
Payment of exercise price or tax liability
$176,228 $40.29 p/Share
4,374 Reduced 5.13%
80,863 Common Stock
Oct 19 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 10.5%
85,237 Common Stock
Jun 16 2021
BUY
Exercise of conversion of derivative security
$5,400 $0.45 p/Share
12,000 Added 13.76%
75,237 Common Stock
Jun 15 2021
SELL
Payment of exercise price or tax liability
$181,868 $58.8 p/Share
3,093 Reduced 4.66%
63,237 Common Stock
Jun 15 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 13.1%
66,330 Common Stock
Jan 27 2021
BUY
Exercise of conversion of derivative security
$810 $0.45 p/Share
1,800 Added 3.1%
56,330 Common Stock

Also insider at

GBIO
Generation Bio Co. Healthcare
KRTX
Karuna Therapeutics, Inc. Healthcare
JMJ

Jeffrey M Jonas

Boston, MA

Track Institutional and Insider Activities on SAGE

Follow Sage Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAGE shares.

Notify only if

Insider Trading

Get notified when an Sage Therapeutics, Inc. insider buys or sells SAGE shares.

Notify only if

News

Receive news related to Sage Therapeutics, Inc.

Track Activities on SAGE